We are live on
!
Find out more
MCM
Marathon Capital Management Portfolio holdings
AUM
$494M
1-Year Est. Return
42.6%
This Fund
S&P 500
This Quarter
Est. Return
+9.43%
1 Year Est. Return
+42.6%
3 Year Est. Return
+70.91%
5 Year Est. Return
+55.81%
10 Year Est. Return
+429.8%
AUM
$419M
AUM Growth
+$21.2M
(+5.3%)
Cap. Flow
-$11.3M
Cap. Flow
% of AUM
-2.7%
Top 10 Holdings %
Top 10 Hldgs %
45.89%
Holding
166
New
13
Increased
44
Reduced
49
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$4.43M |
| 2 |
Transocean
RIG
|
+$3.3M |
| 3 |
Chevron
CVX
|
+$2.65M |
| 4 |
NPKI
NPK International
NPKI
|
+$1.72M |
| 5 |
Symbotic
SYM
|
+$1.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DOC
PHYSICIANS REALTY TRUST
DOC
|
+$6.06M |
| 2 |
Helmerich & Payne
HP
|
+$3.93M |
| 3 |
MDC
M.D.C. Holdings, Inc.
MDC
|
+$3.92M |
| 4 |
Bank of Montreal
BMO
|
+$3.42M |
| 5 |
Xerox
XRX
|
+$2.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 33.19% |
| 2 | Technology | 17.69% |
| 3 | Industrials | 13.06% |
| 4 | Healthcare | 11.44% |
| 5 | Energy | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Marchex
MCHX
$79.7M
| $20.6K | ﹤0.01% |
+15,000
| New | +$20.2K |
|
152
Barfresh Food Group
BRFH
$29.7M
| $18.5K | ﹤0.01% |
15,384
| – | – |
|
153
Kopin
KOPN
$791M
| $18K | ﹤0.01% |
10,000
| – | – |
|
154
Opko Health
OPK
$1.02B
| $18K | ﹤0.01% |
+15,000
| New | +$15K |
|
155
Aqua Metals
AQMS
$10.2M
| – | – |
-75
| Closed | -$11.4K |
|
156
Brighthouse Financial
BHF
$3.49B
| – | – |
-8,086
| Closed | -$428K |
|
157
Blue Bird Corp
BLBD
$2.18B
| – | – |
-46,265
| Closed | -$1.25M |
|
|
158
Bank of Montreal
BMO
$127B
| – | – |
-34,529
| Closed | -$3.42M |
|
159
Citigroup
C
$226B
| – | – |
-7,922
| Closed | -$408K |
|
160
ConocoPhillips
COP
$141B
| – | – |
-7,526
| Closed | -$874K |
|
161
Canadian Pacific Kansas City
CP
$80.5B
| – | – |
-2,905
| Closed | -$230K |
|
162
Oracle
ORCL
$423B
| – | – |
-3,700
| Closed | -$390K |
|
163
Vanguard Dividend Appreciation ETF
VIG
$114B
| – | – |
-1,219
| Closed | -$208K |
|
164
Zymeworks
ZYME
$1.73B
| – | – |
-20,250
| Closed | -$210K |
|
|
MDC
165
DELISTED
M.D.C. Holdings, Inc.
MDC
| – | – |
-70,953
| Closed | -$3.92M |
|
|
DOC
166
DELISTED
PHYSICIANS REALTY TRUST
DOC
| – | – |
-455,584
| Closed | -$6.06M |
|
Similar funds
LI
SAS
BFIC
FSA
TAM
TAA
NYLIC
MA
Marathon Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Marathon Capital Management held 166 positions worth $419M, up 5.3% from $398M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Marathon Capital Management's Q1 2024 filing shows 13 new, 44 increased, 49 reduced and 12 closed positions. Its largest new stake was NPK International: 263,150 shares worth $1.9M. The largest sale was PHYSICIANS REALTY TRUST, an estimated $6.06M.
By sector, the portfolio is most concentrated in Financials at 33% of assets, up from 32% a quarter earlier, followed by Technology and Industrials.
- Marathon Capital Management's largest Q1 2024 buy was NPK International: 263,150 shares worth $1.9M.
- Marathon Capital Management added most to AstraZeneca in Q1 2024, an estimated $4.43M increase.
- Marathon Capital Management's biggest Q1 2024 reduction was Helmerich & Payne, cutting an estimated $3.93M.
- Marathon Capital Management fully exited PHYSICIANS REALTY TRUST in Q1 2024, selling an estimated $6.06M.
- Marathon Capital Management's ten largest holdings make up 46% of its $419M portfolio in Q1 2024.
- Marathon Capital Management opened 13 new positions and closed 12 in Q1 2024.
- Marathon Capital Management's portfolio value rose 5.3% quarter-over-quarter to $419M.
Based on Marathon Capital Management's 13F filing for Q1 2024, filed 15 May 2024.